Drug/Insect/Latex News

The European Commission has approved EURneffy for the emergency treatment of allergic reactions, according to a press release by ARS Pharmaceuticals, producer of the drug.

People with penicillin allergies are more likely to have other antibiotic allergies than those without the allergy, according to a study published in Epic Research.

SAN ANTONIO — With a little patience, physicians can challenge and delabel NSAID hypersensitivity in the office, David A. Khan, MD, said during the 16th Annual Allergy, Asthma & Immunology CME Conference.

The FDA approved an expanded label for Xembify, a 20% subcutaneous immunoglobulin used to treat primary immunodeficiencies produced by Grifols, according to a company press release.

Hospitalized pediatric patients who were given direct oral challenges for penicillin allergies saw success in delabeling, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Hypersensitivity to polyethylene glycol may be rare, but when reactions to PEG in drugs do occur, they often are due to molecular weights of 3350 and higher, according to a study published in Annals of Allergy, Asthma & Immunology.

Hypersensitivity to polyethylene glycols is not a common cause of anaphylaxis induced by drugs, according to a study published in Annals of Allergy, Asthma & Immunology.

Researchers found that a questionnaire successfully identified patients with STIs who can be safely evaluated for penicillin allergy by skin test or by a two-step graded oral challenge, according to a study.

Intrinsic factors such as blood type, medical history, allergies and family history contribute to the risk for developing alpha-gal syndrome, according to a study published in Annals of Allergy, Asthma & Immunology.

Nonallergy health care professionals can safely perform direct oral penicillin challenges to delabel low-risk patients, according to a study published in Journal of Infection.